The Economic Burden Of Dasatinib And Nilotinib Treatment Failure In Chronic Myeloid Leukemia (Cml) Patients- A Real-World Analysis

May 1, 2013, 00:00
10.1016/j.jval.2013.03.669
https://www.valueinhealthjournal.com/article/S1098-3015(13)00740-7/fulltext
Title : The Economic Burden Of Dasatinib And Nilotinib Treatment Failure In Chronic Myeloid Leukemia (Cml) Patients- A Real-World Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00740-7&doi=10.1016/j.jval.2013.03.669
First page : A137
Section Title : Cancer
Open access? : No
Section Order : 217
Categories :
Tags :
Regions :
ViH Article Tags :